In the present study, integrative multiomics analysis identified six candidate genes, CTHRC1, TWF2, COL6A3, SLC38A5, IFI44, and OASL, associated with RCC progression and therapeutic resistance. Here, COL6A3 is linked to renal cell carcinoma.